Read Our Blog

Read More

The new Children’s National Research & Innovation Campus welcomed our Rare Disease Institute as its first occupant and saw its first patient last month. A $5 million gift from The Boeing Company will drive discoveries at the new campus.

Read More

A five-year, $3.85 million commitment form Takeda Pharmaceuticals will help the Children's National Hospital Rare Disease Institute launch a first-of-its-kind rare disease clinical protocol program to support families, caregivers, clinicians and researchers.

Read More